🔎 Trials Near Me

Gara Jalqabaatti › Saree Oljoo › Louisiana › New Orleans

Qorannoo klinikaalii Saree Oljoo New Orleans, LA keessatti

Qorannoo 11 Saree Oljoo f New Orleans fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
  • West Jefferson Medical Center, Marrero · Miili 4 fagaatti
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Namoota walitti qabaa jiraSadarkaa 3
  • Ochsner Clinic Foundation ( Site 0021), New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Namoota walitti qabaa jiraSadarkaa 3
  • University Medical Center-New Orleans, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06492616

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Ochsner Medical Center (OMC), New Orleans
Umuriin 18 hanga 55 · Dubartoota · Haaromfame 09-Ful-2026 · NCT07310420

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Namoota walitti qabaa jiraSadarkaa 3
  • Care Access-Marrero, Marrero · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Namoota walitti qabaa jiraSadarkaa 3
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
  • fi 1 dabalataa
Umuriin 18 hanga 60 · Dubartoota · Haaromfame 02-Ful-2026 · NCT05879926

E-Mindfulness Approaches for Living After Breast Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University Medical Center New Orleans, New Orleans
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06748222

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Louisiana State University Health Sciences Center, New Orleans
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT05768139

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Namoota walitti qabaa jiraSadarkaa 3
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
Umuriin 50 hanga 70 · Saalaa hunda · Haaromfame 23-Elb-2026 · NCT04852887

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, New Orleans
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Louisiana State University, New Orleans
Umuriin 18 fi ol · Dubartoota · Haaromfame 07-Ama-2025 · NCT06230185

Qorannoo Saree Oljoo magaalota biroo keessatti

Qorannoo biroo New Orleans keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.